The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

Phage lysin compound HY-133: Start of clinical phase I “first-in-human” study to eliminate Staphylococcus aureus
Clinical & Manufacturing

Phage lysin compound HY-133: Start of clinical phase I “first-in-human” study to eliminate Staphylococcus aureus

SEP 1, 2024
A virally-encoded tRNA neutralizes the PARIS antiviral defense system
Pharma & Human Health

A virally-encoded tRNA neutralizes the PARIS antiviral defense system

SEP 1, 2024
Revealing the mysteries within microbial genomes
Pharma & Human Health

Revealing the mysteries within microbial genomes

SEP 1, 2024
Morinaga Milk Obtains the Registration of “New Food Ingredient” in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods
Biotics and Supplements

Morinaga Milk Obtains the Registration of “New Food Ingredient” in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods

SEP 1, 2024
Researchers develop probiotic to ameliorate ulcerative colitis
Biotics and Supplements

Researchers develop probiotic to ameliorate ulcerative colitis

SEP 1, 2024
Mining the microbiome: Uncovering new antibiotics inside the human gut
Infectious Disease & AMR

Mining the microbiome: Uncovering new antibiotics inside the human gut

AUG 27, 2024
Ferring v Finch: Ripples from the Decision
Editor's Choice

Ferring v Finch: Ripples from the Decision

AUG 14, 2024
Transferring an LBP program from one CDMO to another
Finance

Transferring an LBP program from one CDMO to another

JUL 31, 2024
Viruses use freeloading genes as weapons
Pharma & Human Health

Viruses use freeloading genes as weapons

JUL 26, 2024
Ancilia Biosciences Announces Closing of $4.2 Million Financing
Finance

Ancilia Biosciences Announces Closing of $4.2 Million Financing

JUL 18, 2024
Eligo Publishes a Landmark Study in Nature That Unlocks Genome Editing of Bacteria in the Gut
Editor's Choice

Eligo Publishes a Landmark Study in Nature That Unlocks Genome Editing of Bacteria in the Gut

JUL 10, 2024